• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者的体内31P磁共振波谱研究:疾病严重程度无创评估的进展

An in vivo 31P MRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity.

作者信息

Munakata T, Griffiths R D, Martin P A, Jenkins S A, Shields R, Edwards R H

机构信息

Magnetic Resonance Research Centre, University of Liverpool, UK.

出版信息

NMR Biomed. 1993 Mar-Apr;6(2):168-72. doi: 10.1002/nbm.1940060211.

DOI:10.1002/nbm.1940060211
PMID:8499248
Abstract

Fourteen patients with liver cirrhosis of differing severity participated in a one-dimensional chemical shift imaging 31P MRS study of the liver. Patients were divided into two groups according to the severity of their liver disease using Child's classification and the aminopyrine breath test (AB test). Seven normal volunteers without liver disease acted as controls. The phosphomonester (PME) peak in normal subjects was 4.77% (95% confidence interval, CI: 4.11-5.42) of total phosphorus. The PME peak was significantly elevated in both mild cirrhosis [5.80% (95% CI: 5.46-6.14), p = 0.0051, vs normal subjects] and severe cirrhosis [9.64% (95% CI: 8.71-10.57), p = 0.0002, vs normal subjects and p = 0.001, vs mild cirrhosis]. There was a significant negative linear correlation (r = 0.88, p < 0.01) of PME with the percentage dose of 14CO2 excreted over 2 h in the AB test. pH values in patients with mild cirrhosis [7.45 (95% CI: 7.35-7.55)] but not severe cirrhosis [7.36 (95% CI: 7.25-7.47)] were significantly elevated (p = 0.04) compared to normal subjects [7.29 (95% CI: 7.17-7.41)]. Comparison of the peak area of PME at TR = 0.5 s against that using TR = 5.0 s in cirrhotic liver suggested no reduction in T1 of phosphorus metabolites in cirrhosis. A relationship between the severity of liver cirrhosis and a relative increase in PME was demonstrated and this was not due to a reduction of T1. This study highlights the clinical potential of 31P MRS as a non-invasive means of assessing the severity of liver cirrhosis.

摘要

14例不同严重程度的肝硬化患者参与了肝脏的一维化学位移成像31P磁共振波谱研究。根据Child分级和氨基比林呼吸试验(AB试验),将患者按肝病严重程度分为两组。7名无肝病的正常志愿者作为对照。正常受试者的磷酸单酯(PME)峰占总磷的4.77%(95%置信区间,CI:4.11 - 5.42)。轻度肝硬化患者的PME峰[5.80%(95%CI:5.46 - 6.14),与正常受试者相比,p = 0.0051]和重度肝硬化患者的PME峰[9.64%(95%CI:8.71 - 10.57),与正常受试者相比,p = 0.0002,与轻度肝硬化相比,p = 0.001]均显著升高。在AB试验中,PME与2小时内呼出的14CO2百分比剂量呈显著负线性相关(r = 0.88,p < 0.01)。与正常受试者[7.29(95%CI:7.17 - 7.41)]相比,轻度肝硬化患者的pH值[7.45(95%CI:7.35 - 7.55)]显著升高(p = 0.04),而重度肝硬化患者的pH值[7.36(95%CI:7.25 - 7.47)]则未显著升高。在肝硬化肝脏中,比较TR = 0.5 s时与TR = 5.0 s时PME的峰面积,提示肝硬化时磷代谢物的T1未降低。研究表明肝硬化严重程度与PME相对增加之间存在关联,且这并非由于T1降低所致。本研究突出了31P磁共振波谱作为评估肝硬化严重程度的非侵入性手段的临床潜力。

相似文献

1
An in vivo 31P MRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity.肝硬化患者的体内31P磁共振波谱研究:疾病严重程度无创评估的进展
NMR Biomed. 1993 Mar-Apr;6(2):168-72. doi: 10.1002/nbm.1940060211.
2
Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.功能分级和病因对肝硬化患者体内肝脏磷-31磁共振波谱的影响:波谱表现的生化基础
Hepatology. 1995 Feb;21(2):417-27.
3
High resolution in vivo 31P-MRS of the liver: potential advantages in the assessment of non-alcoholic fatty liver disease.肝脏的高分辨率活体31P磁共振波谱分析:在非酒精性脂肪性肝病评估中的潜在优势
Acta Radiol. 2015 Sep;56(9):1051-60. doi: 10.1177/0284185114550850. Epub 2014 Sep 30.
4
[The relationship between 31P magnetic resonance spectroscopy and the histopathology of livers of chronic viral hepatitis patients].[31P磁共振波谱与慢性病毒性肝炎患者肝脏组织病理学的关系]
Zhonghua Gan Zang Bing Za Zhi. 2007 May;15(5):338-41.
5
The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C.慢性丙型肝炎中体内31P磁共振波谱与组织学的关系。
Hepatology. 2003 Apr;37(4):788-94. doi: 10.1053/jhep.2003.50149.
6
A comparison of 31P magnetic resonance spectroscopy and microbubble-enhanced ultrasound for characterizing hepatitis c-related liver disease.31P 磁共振波谱与超声微泡增强技术在诊断丙型肝炎相关肝病中的对比研究。
J Viral Hepat. 2011 Oct;18(10):e530-4. doi: 10.1111/j.1365-2893.2011.01455.x. Epub 2011 Apr 4.
7
Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques.使用化学位移成像技术对人体肝脏进行磷-31磁共振波谱分析。
J Hepatol. 1992 Mar;14(2-3):265-75. doi: 10.1016/0168-8278(92)90169-p.
8
Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models.原发性胆汁性肝硬化的肝脏磷-31磁共振波谱分析及其与预后模型的关系。
Gut. 1996 Jul;39(1):141-6. doi: 10.1136/gut.39.1.141.
9
MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra.慢性肝病基底节的磁共振成像与波谱分析:T1加权对比测量值与质子和磷-31磁共振波谱异常的相关性
Metab Brain Dis. 1996 Sep;11(3):249-68. doi: 10.1007/BF02237962.
10
[Assessment of functional severity on in vivo hepatic 31P-MRS in diffuse hepatic disease: comparative studies with 99mTc-GSA].[弥漫性肝病患者肝脏31P-MRS体内功能严重程度评估:与99mTc-GSA的对比研究]
Nihon Igaku Hoshasen Gakkai Zasshi. 2000 Jul;60(8):439-44.

引用本文的文献

1
Non-Invasive Analysis of Human Liver Metabolism by Magnetic Resonance Spectroscopy.磁共振波谱法对人体肝脏代谢的无创分析
Metabolites. 2021 Oct 29;11(11):751. doi: 10.3390/metabo11110751.
2
Absolute Quantification of Phosphor-Containing Metabolites in the Liver Using P MRSI and Hepatic Lipid Volume Correction at 7T Suggests No Dependence on Body Mass Index or Age.使用 7T 的 P MRSI 和肝脂质容积校正进行肝脏含磷代谢物的绝对定量提示其与体重指数或年龄无关。
J Magn Reson Imaging. 2019 Feb;49(2):597-607. doi: 10.1002/jmri.26225. Epub 2018 Oct 6.
3
Metabolic profiling of the rat liver after chronic ingestion of alpha-naphthylisothiocyanate using in vivo and ex vivo magnetic resonance spectroscopy.
采用体内和离体磁共振波谱法研究慢性摄入α-萘基异硫氰酸酯后大鼠肝脏的代谢谱。
Toxicol Sci. 2012 Apr;126(2):306-16. doi: 10.1093/toxsci/kfs019. Epub 2012 Jan 18.
4
Biochemical metabolic changes assessed by 31P magnetic resonance spectroscopy after radiation-induced hepatic injury in rabbits.用31P磁共振波谱评估兔辐射性肝损伤后的生化代谢变化。
World J Gastroenterol. 2009 Jun 14;15(22):2723-30. doi: 10.3748/wjg.15.2723.
5
In vivo, high-field, 3-Tesla 1H MR spectroscopic assessment of liver fibrosis in HCV-correlated chronic liver disease.体内高场强3特斯拉1H磁共振波谱对丙型肝炎病毒相关慢性肝病肝纤维化的评估
Radiol Med. 2008 Mar;113(2):289-99. doi: 10.1007/s11547-008-0239-8. Epub 2008 Apr 2.
6
Etiology and functional status of liver cirrhosis by 31P MR spectroscopy.通过磷-31磁共振波谱分析肝硬化的病因及功能状态
World J Gastroenterol. 2005 Nov 28;11(44):6926-31. doi: 10.3748/wjg.v11.i44.6926.
7
Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease.通过局部体内31P核磁共振波谱法对弥漫性肝病患者肝脏代谢物浓度进行绝对定量分析。
Eur Radiol. 2005 Jan;15(1):148-57. doi: 10.1007/s00330-004-2434-x. Epub 2004 Sep 3.
8
Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease.慢性肝病大鼠模型中的肝脏31P磁共振波谱分析:评估疾病的程度和进展
Gut. 2003 Jul;52(7):1046-53. doi: 10.1136/gut.52.7.1046.
9
In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts.人肝同种异体移植慢性胆管缺失性排斥反应的体内外肝脏磷-31磁共振波谱分析及电子显微镜检查
Gut. 1998 May;42(5):735-43. doi: 10.1136/gut.42.5.735.
10
Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models.原发性胆汁性肝硬化的肝脏磷-31磁共振波谱分析及其与预后模型的关系。
Gut. 1996 Jul;39(1):141-6. doi: 10.1136/gut.39.1.141.